CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,160,147 | -9.6% | 1,910,984 | +3.8% | 0.00% | – |
| Q3 2022 | $12,340,000 | +84.4% | 1,841,770 | +15.9% | 0.00% | – |
| Q2 2022 | $6,691,000 | +126.0% | 1,589,198 | +81.0% | 0.00% | – |
| Q1 2022 | $2,960,000 | -22.6% | 878,161 | -27.7% | 0.00% | – |
| Q4 2021 | $3,826,000 | -5.5% | 1,214,616 | -1.9% | 0.00% | – |
| Q3 2021 | $4,049,000 | -22.5% | 1,237,960 | -0.0% | 0.00% | – |
| Q2 2021 | $5,224,000 | -24.7% | 1,238,016 | -10.9% | 0.00% | – |
| Q1 2021 | $6,937,000 | -57.7% | 1,390,066 | +7.2% | 0.00% | – |
| Q4 2020 | $16,388,000 | +32.4% | 1,296,501 | +2.8% | 0.00% | – |
| Q3 2020 | $12,380,000 | -2.0% | 1,260,681 | -0.7% | 0.00% | – |
| Q2 2020 | $12,634,000 | +18.4% | 1,269,758 | +5.2% | 0.00% | – |
| Q1 2020 | $10,667,000 | +10.5% | 1,206,716 | +15.3% | 0.00% | – |
| Q4 2019 | $9,655,000 | +56.1% | 1,046,594 | -0.5% | 0.00% | – |
| Q3 2019 | $6,185,000 | -48.9% | 1,051,889 | +4.4% | 0.00% | – |
| Q2 2019 | $12,096,000 | +4.6% | 1,007,995 | +5.2% | 0.00% | – |
| Q1 2019 | $11,569,000 | -6.3% | 958,493 | -2.6% | 0.00% | -100.0% |
| Q4 2018 | $12,352,000 | -32.1% | 984,246 | -19.7% | 0.00% | 0.0% |
| Q3 2018 | $18,192,000 | -4.7% | 1,225,849 | +8.1% | 0.00% | 0.0% |
| Q2 2018 | $19,088,000 | -22.7% | 1,134,190 | +5.1% | 0.00% | 0.0% |
| Q1 2018 | $24,704,000 | +23.0% | 1,078,777 | +39.0% | 0.00% | 0.0% |
| Q4 2017 | $20,084,000 | +83.6% | 776,375 | +4.7% | 0.00% | 0.0% |
| Q3 2017 | $10,940,000 | +3.7% | 741,678 | -2.0% | 0.00% | 0.0% |
| Q2 2017 | $10,553,000 | -9.3% | 756,513 | +11.0% | 0.00% | 0.0% |
| Q1 2017 | $11,630,000 | +75.8% | 681,712 | +6.1% | 0.00% | – |
| Q4 2016 | $6,615,000 | +4.5% | 642,820 | +2.6% | 0.00% | – |
| Q3 2016 | $6,331,000 | -7.0% | 626,258 | +3.3% | 0.00% | – |
| Q2 2016 | $6,809,000 | -14.4% | 606,359 | +4.1% | 0.00% | -100.0% |
| Q1 2016 | $7,957,000 | -21.6% | 582,474 | +8.8% | 0.00% | 0.0% |
| Q4 2015 | $10,153,000 | -94.3% | 535,269 | -90.2% | 0.00% | -85.7% |
| Q3 2015 | $179,101,000 | +2742.0% | 5,488,236 | +1196.7% | 0.01% | – |
| Q2 2015 | $6,302,000 | +13.4% | 423,238 | +15.4% | 0.00% | – |
| Q1 2015 | $5,555,000 | +18.8% | 366,863 | +4.6% | 0.00% | – |
| Q4 2014 | $4,674,000 | -9.0% | 350,863 | -13.8% | 0.00% | – |
| Q3 2014 | $5,135,000 | +545.1% | 407,212 | +417.2% | 0.00% | – |
| Q2 2014 | $796,000 | +70.4% | 78,734 | +127.0% | 0.00% | – |
| Q1 2014 | $467,000 | – | 34,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |